Skip to main content
Log in

Prognostic models in the clinical arena

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Making a prognosis is to predict the course of a disease and estimate the probability (or risk) of the appearance of a given outcome in relationship to clinical or non-clinical characteristics. Prognostic assessment is usually modelled by multivariable mathematic equations (prognostic models). In this article we describe what a prognostic model is, how to build a good one, why and how it is important to evaluate its generalizability and accuracy by means of discrimination, calibration and reclassification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Todd JH, Dowle C, Williams MR et al. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987; 56: 489–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kannel WB, D’Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159: 1197–204.

    Article  CAS  PubMed  Google Scholar 

  3. Tripepi G, Jager KJ, Dekker FW, Zoccali C. Testing for causality and prognosis: etiological and prognostic models. Kidney Int 2008; 74: 1512–5.

    Article  PubMed  Google Scholar 

  4. Tripepi G, Jager KJ, Dekker FW, Zoccali C. Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. Nephrol Dial Transplant 2010; 25: 1399–401.

    Article  CAS  PubMed  Google Scholar 

  5. Tripepi G, Jager KJ, Dekker FW, Zoccali C. Statistical methods for the assessment of prognostic biomarkers (part II): calibration and reclassification. Nephrol Dial Transplant 2010; 25: 1402–5.

    Article  CAS  PubMed  Google Scholar 

  6. Reynolds T. The triple test as a screening technique for Down syndrome: reliability and relevance. Int J Womens Health 2010; 2: 83–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ito K, Yamamoto T, Ohi M, Kurokawa K, Suzuki K, Yamanaka H. Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL. Urology 2003; 61: 760–4.

    Article  PubMed  Google Scholar 

  8. Euser AM, Zoccali C, Jager KJ, Dekker FW. Cohort studies: prospective versus retrospective. Nephron Clin Pract 2009; 113: c214–7.

    Article  PubMed  Google Scholar 

  9. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med 2007; 120: 953–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mendelssohn DC, Pisoni RL, Arrington CJ et al. A practice-related risk score (PRS): a DOPPS-derived aggregate quality index for haemodialysis facilities. Nephrol Dial Transplant 2008; 23: 3227–33.

    Article  PubMed  Google Scholar 

  11. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP; INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002; 136: 438–48.

    Article  PubMed  Google Scholar 

  12. Pencina MJ, D’Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation 2009; 119: 3078–84.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 2001; 344: 467–71.

    Article  CAS  PubMed  Google Scholar 

  14. Ho KM, Lee KY, Williams T, Finn J, Knuiman M, Webb SA. Comparison of Acute Physiology and Chronic Health Evaluation (APACHE) II score with organ failure scores to predict hospital mortality. Anaesthesia 2007; 62: 466–73.

    Article  CAS  PubMed  Google Scholar 

  15. Wijdicks EF. Clinical scales for comatose patients: the Glasgow Coma Scale in historical context and the new FOUR Score. Rev Neurol Dis 2006; 3: 109–17.

    PubMed  Google Scholar 

  16. McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY. Assessing new biomarkers and predictive models for use in clinical practice: a clinician’s guide. Arch Intern Med 2008; 168: 2304–10.

    Article  PubMed  Google Scholar 

  17. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293–8.

    Article  CAS  PubMed  Google Scholar 

  18. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16: 965–80.

    Article  CAS  PubMed  Google Scholar 

  19. Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ. Survival analysis II: Cox regression. Nephron Clin Pract 2011; 119: c255–60.

    Article  PubMed  Google Scholar 

  20. Talmud PJ, Hingorani AD, Cooper JA et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010; 340: b4838. doi: 10.1136/bmj.b4838.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Davide Bolignano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolignano, D., Mattace-Raso, F., Torino, C. et al. Prognostic models in the clinical arena. Aging Clin Exp Res 24, 300–304 (2012). https://doi.org/10.1007/BF03325262

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03325262

Key words

Navigation